Cytosorbents Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -39.2% | -39.2% | -27.4% |
| FY2022 | -92.8% | -81.3% | -51.9% |
| FY2023 | -124.6% | -112.4% | -55.2% |
| FY2024 | -186.5% | -82.5% | -43.7% |
| FY2025 | -138.9% | -36.3% | -18.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -39.2% | -39.2% | -27.4% |
| FY2022 | -92.8% | -81.3% | -51.9% |
| FY2023 | -124.6% | -112.4% | -55.2% |
| FY2024 | -186.5% | -82.5% | -43.7% |
| FY2025 | -138.9% | -36.3% | -18.6% |